BGJ398: Selective FGFR Inhibitor for Oncology & Developme...
2025-10-18
BGJ398 (NVP-BGJ398) stands out as a highly selective FGFR inhibitor, enabling targeted investigation of FGFR-driven malignancies and developmental pathways. This guide delivers hands-on protocols, troubleshooting strategies, and comparative insights to maximize research impact in cancer and embryogenesis models.